Presentation is loading. Please wait.

Presentation is loading. Please wait.

Dengue Prevention in Asia

Similar presentations


Presentation on theme: "Dengue Prevention in Asia"— Presentation transcript:

1 Dengue Prevention in Asia

2 Part 1: Overview of Dengue

3 What Is Dengue?

4 WHO Dengue Case Classification

5 Prevalence and Disease Burden of Dengue

6 Dengue Serotypes

7 Global Distribution of Dengue, 2012

8 Global Dengue Transmission Map - Thailand

9 Social Impact of Dengue

10 Asymptomatic Individuals and Transmission

11 Getting Dengue More Than Once

12 Why Does Severe Dengue Occur?

13 Prevention of Dengue Infection

14 Dengue CYD-TDV

15 Efficacy of CYD-TDV

16 Efficacy of CYD-TDV (cont)

17 Part 2: Dengue Q&A

18 Question: Why is the dengue vaccine not recommended in children aged < 9 years?

19 Vaccination Age Recommendations

20 Question: What did the WHO recommend in July 2016 for countries considering introducing the CYD-TDV?

21 WHO Recommendation, July 2016

22 Question: What did the additional analysis provided to WHO conclude?

23 Results of Additional Analysis of Dengue Vaccine Data

24 Question: Why is there a higher risk of severe dengue in seronegative people who receive the vaccine?

25 Higher Severe Dengue Risk in Seronegative People Who Receive the Vaccine

26 Higher Severe Dengue Risk in Seronegative People Who Receive the Vaccine (cont)

27 Question: What happens to people who have breakthrough dengue after being vaccinated?

28 Breakthrough Dengue After Vaccination

29 Question: Has the WHO updated it position as a result of this analysis?

30 Updated WHO Position, December 2017

31 Question: Why did the vaccine manufacturer request a label update in November 2017?

32 Vaccine Label Update Request

33 Question: Why have some countries recently begun re-examining their use of dengue vaccine?

34 Re-Examination of Vaccine Use in Asia

35 Question: Are people previously infected with dengue likely to know that they had the disease?

36 Awareness of Previous Dengue Infection

37 Question: How can a physician determine whether or not a patient should receive the vaccine?

38 Deciding Whether to Vaccinate

39 Questions from patients and parents

40 Considerations When Vaccinating Children

41 Other Considerations

42 Vaccine Side Effects

43 Summary

44 Abbreviations


Download ppt "Dengue Prevention in Asia"

Similar presentations


Ads by Google